Mylan’s Dutch takeover defense is in Nasdaq

Steven Davidoff Solomon writes for The New York Times, June 11, 2015

These days, the pharmaceutical company Mylan is both the hunter and the hunted. The question is whether Mylan’s defense against a takeover attempt will run afoul of United States market rules and whether those rules will be enforced.